glp-1 and pregnancy Maternal receptor activation inhibits fetal growth GLP-1 Drug Discontinuation Raises Pregnancy

GLP-ONE Support Multivitamin Nutrient Renewal is designed to address the unique nutritional gaps commonly seen in patients taking GLP-1 RA medications.*

#retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor

Its not clear why Tirzepatide isnt being tested for the same diseases (it could be a commercial decision rather than a medical one)

In a 6-week randomized phase 1 trial, tirzepatide led to reduced caloric intake during a meal test at week 3 compared with placebo and liraglutide in people with overweight or obesity.

FDA updates rules on compounded GLP-1 drugs, impacting patients and providers

WHAT YOU CAN EXPECT: With consistent daily use many users notice early improvements in gut health, bowel regularity, and overall digestion within the first 10 days